High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive Antiretroviral Therapy in HIV Infection

Journal of Acquired Immune Deficiency Syndromes - United States
doi 10.1097/qai.0000000000000617
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Antiretroviral Therapy in HIV Infection

Archives of Neurology
2004English

Growth in HIV-infected Children on Long-Term Antiretroviral Therapy

Tropical Medicine and International Health
EnvironmentalParasitologyInfectious DiseasesPublic HealthOccupational Health
2016English

Residual HIV-1 RNA in Blood Plasma of Patients Taking Suppressive Highly Active Antiretroviral Therapy

JAMA - Journal of the American Medical Association
Medicine
1999English

Vitamin D Levels and Markers of Inflammation and Metabolism in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

AIDS Research and Human Retroviruses
VirologyInfectious DiseasesImmunology
2016English

Improving Antiretroviral Therapy in Children With Hiv Infection

CHILDREN INFECTIONS
2018English

High Plasma Serotonin Levels in Primary Pulmonary Hypertension : Effect of Long-Term Epoprostenol (Prostacyclin) Therapy

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2000English

Epidemiological, Clinical and Financial Components of Results of Longterm Antiretroviral Therapy of Patients With Hivinfection

HIV Infection and Immunosuppressive Disorders
EnvironmentalPublic HealthInfectious DiseasesImmunologyOccupational Health
2020English

The Evaluation of Virological and Immunological Response to Antiretroviral Therapy in HIV/AIDS Cases

Ankem Dergisi
2012English

VDR Polymorphisms Influence Immunological Response in HIV-1+ Individuals Undergoing Antiretroviral Therapy

Genetics and Molecular Biology
GeneticsMolecular Biology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy